The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AC IMMUNE SA | SHS | H00263105 | 10,589 | 1,242,843 | SH | SOLE | 1,242,843 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 6,283 | 247,178 | SH | SOLE | 247,178 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 8,298 | 1,428,277 | SH | SOLE | 1,428,277 | 0 | 0 | ||
ALLAKOS INC | PUT | 01671P950 | 1,974 | 20,700 | SH | Put | SOLE | 20,700 | 0 | 0 | |
ANAPTYSBIO INC | COM | 032724106 | 3,816 | 234,823 | SH | SOLE | 234,823 | 0 | 0 | ||
APOLLO ENDOSURGERY INC | COM | 03767D108 | 454 | 159,336 | SH | SOLE | 159,336 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 14,904 | 328,129 | SH | SOLE | 328,129 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | CALL | 040047907 | 6,468 | 142,400 | SH | Call | SOLE | 142,400 | 0 | 0 | |
ARQULE INC | COM | 04269E107 | 8,989 | 450,326 | SH | SOLE | 450,326 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | PUT | 05464T954 | 620 | 6,000 | SH | Put | SOLE | 6,000 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 7,841 | 92,737 | SH | SOLE | 92,737 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 520 | 8,100 | SH | SOLE | 8,100 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 2,669 | 391,894 | SH | SOLE | 391,894 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 8,978 | 142,800 | SH | SOLE | 142,800 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 2,309 | 11,293 | SH | SOLE | 11,293 | 0 | 0 | ||
CUE BIOPHARMA INC | COM | 22978P106 | 2,185 | 137,628 | SH | SOLE | 137,628 | 0 | 0 | ||
ENVISTA HLDGS CORP | COM | 29415F104 | 4,891 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
EVOLENT HEALTH INC | CL A | 30050B101 | 2,528 | 279,390 | SH | SOLE | 279,390 | 0 | 0 | ||
EVOLUS INC | COM | 30052C107 | 2,884 | 236,939 | SH | SOLE | 236,939 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 3,566 | 224,702 | SH | SOLE | 224,702 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,756 | 388,600 | SH | SOLE | 388,600 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,283 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 14,245 | 1,036,000 | SH | SOLE | 1,036,000 | 0 | 0 | ||
MEIRAGTX HOLDINGS PLC | COM | G59665102 | 10,367 | 517,844 | SH | SOLE | 517,844 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 616 | 38,481 | SH | SOLE | 38,481 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 2,250 | 160,883 | SH | SOLE | 160,883 | 0 | 0 | ||
ORGANOGENESIS HLDGS INC | COM | 68621F102 | 2,972 | 617,836 | SH | SOLE | 617,836 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 1,814 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
PERSONALIS INC | COM | 71535D106 | 4,433 | 406,673 | SH | SOLE | 406,673 | 0 | 0 | ||
R1 RCM INC | COM | 749397105 | 2,596 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 12,859 | 62,900 | SH | SOLE | 62,900 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 2,630 | 1,258,224 | SH | SOLE | 1,258,224 | 0 | 0 | ||
TELIGENT INC NEW | COM | 87960W104 | 632 | 1,484,527 | SH | SOLE | 1,484,527 | 0 | 0 | ||
TRINET GROUP INC | COM | 896288107 | 1,591 | 28,104 | SH | SOLE | 28,104 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 17,019 | 237,500 | SH | SOLE | 237,500 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 14,198 | 161,195 | SH | SOLE | 161,195 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 7,264 | 217,686 | SH | SOLE | 217,686 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 19,458 | 130,000 | SH | SOLE | 130,000 | 0 | 0 |